Home/Pipeline/Undisclosed Infectious Disease Program(s)

Undisclosed Infectious Disease Program(s)

Infectious Diseases

Pre-clinicalActive

Key Facts

Indication

Infectious Diseases

Phase

Pre-clinical

Status

Active

Company

ATB therapeutics

About ATB therapeutics

ATB Therapeutics is a private, pre-clinical stage biotech developing a proprietary platform for targeted antibody-based therapies. Its core technology aims to create highly specific biologics for infectious diseases and cancer, potentially offering improved efficacy and reduced side effects. The company is at an early stage, advancing its internal pipeline while seeking strategic partnerships. Its success hinges on validating its platform in the clinic and navigating the competitive landscape of targeted biologics.

View full company profile

Therapeutic Areas

Infectious Diseases Oncology

Other Infectious Diseases Drugs

Drug	Company	Phase	Status
inPROBE Platform	SDS Optic	Early R&D	Active
Potential Human POC Diagnostics	MatMaCorp	Research	Active
Nanoparticle Vaccines	Opko Health	Research	Active
Platform Vaccine Applications	Chimeron Bio	Discovery	Research
FMN riboswitch modulator	Acellera	Pre-clinical	Hit Identification
NP-G2-044	Novita Pharmaceuticals	Pre-Clinical	Exploratory
Ramoplanin™	Nanopharmaceutics	Clinical	Active
NanoDOX™	Nanopharmaceutics	Clinical	Active
Infectious Diseases	Menarini	Clinical	Active
Vaccines for Infectious Diseases (undisclosed)	Takis	Pre-clinical	Active
Infectious Disease Diagnostics Program	Aptus Biosciences	Discovery	Active
Undisclosed Multispecific Therapeutics	ModeX Therapeutics	Pre-clinical	Active